{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:07:47Z","timestamp":1784038067392,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019353","name":"Belgian Health Care Knowledge Centre","doi-asserted-by":"publisher","award":["18-1128"],"award-info":[{"award-number":["18-1128"]}],"id":[{"id":"10.13039\/501100019353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"DOI":"10.1007\/s11096-026-02112-4","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:33:04Z","timestamp":1773901984000},"page":"1359-1369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A qualitative process evaluation of a clinical trial on bedside model-informed precision dosing of vancomycin in critically ill children"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3666-8128","authenticated-orcid":false,"given":"Lise-Marie","family":"Kinnaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Amza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7634-7471","authenticated-orcid":false,"given":"Pieter","family":"De Cock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"1","key":"2112_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40272-020-00426-y","volume":"23","author":"J Willems","year":"2021","unstructured":"Willems J, Hermans E, Schelstraete P, et al. Optimizing the use of antibiotic agents in the Pediatric Intensive Care Unit: a narrative review. Paediatr Drugs. 2021;23(1):39\u201353. https:\/\/doi.org\/10.1007\/s40272-020-00426-y.","journal-title":"Paediatr Drugs"},{"issue":"11","key":"2112_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835\u201364. https:\/\/doi.org\/10.1093\/ajhp\/zxaa036.","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"2112_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5863\/1551-6776-25.6.476","volume":"25","author":"JT Pham","year":"2020","unstructured":"Pham JT. Challenges of vancomycin dosing and therapeutic monitoring in neonates. J Pediatr Pharmacol Ther. 2020;25(6):476\u201384. https:\/\/doi.org\/10.5863\/1551-6776-25.6.476.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"2","key":"2112_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11096-021-01345-9","volume":"44","author":"A van der Veen","year":"2022","unstructured":"van der Veen A, Somers A, Vanhaesebrouck S, et al. Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units. Int J Clin Pharm. 2022;44(2):564\u20139. https:\/\/doi.org\/10.1007\/s11096-021-01345-9.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"2112_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cpt.2202","volume":"109","author":"SG Wicha","year":"2021","unstructured":"Wicha SG, M\u00e4rtson AG, Nielsen EI, et al. From therapeutic drug monitoring to model-informed precision dosing for antibiotics. Clin Pharmacol Ther. 2021;109(4):928\u201341. https:\/\/doi.org\/10.1002\/cpt.2202.","journal-title":"Clin Pharmacol Ther"},{"key":"2112_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02042-17","author":"MN Neely","year":"2018","unstructured":"Neely MN, Kato L, Youn G, et al. Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother. 2018. https:\/\/doi.org\/10.1128\/AAC.02042-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2112_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcph.2363","volume":"64","author":"JJ Yang","year":"2024","unstructured":"Yang JJ, Brett J, Sordo A, et al. The influence of a therapeutic drug monitoring service on vancomycin-associated nephrotoxicity. J Clin Pharmacol. 2024;64(1):19\u201329.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"2112_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2363","volume":"11","author":"NM Hall","year":"2024","unstructured":"Hall NM, Brown ML, Edwards WS, et al. Model-informed precision dosing improves outcomes in patients receiving vancomycin for Gram-positive infections. Open Forum Infect Dis. 2024;11(1):ofae002. https:\/\/doi.org\/10.1002\/jcph.2363.","journal-title":"Open Forum Infect Dis"},{"key":"2112_CR9","unstructured":"TDM-monography. Therapeutic Drug Monitoring en Farmacogenetica Monografie\u00ebn 2024 [Available from: https:\/\/tdm-monografie.org\/monografieen\/tdm-monografieen\/. Accessed 06 June 2025."},{"key":"2112_CR10","unstructured":"Belgian Center for Pharmacotherapeutic Information. Summary of Product Characteristics of vancomycine [Available from: https:\/\/www.bcfi.be\/nl\/chapters\/12?frag=18036&view=pvt&vmp_group=35956. Accessed 28 May 2025."},{"issue":"5","key":"2112_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/cpt.659","volume":"101","author":"AS Darwich","year":"2017","unstructured":"Darwich AS, Ogungbenro K, Vinks AA, et al. Why has model-informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future. Clin Pharmacol Ther. 2017;101(5):646\u201356. https:\/\/doi.org\/10.1002\/cpt.659.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2112_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/cpt.204","volume":"109","author":"F Kluwe","year":"2021","unstructured":"Kluwe F, Michelet R, Mueller-Schoell A, et al. Perspectives on model-informed precision dosing in the digital health era: challenges, opportunities, and recommendations. Clin Pharmacol Ther. 2021;109(1):29\u201336. https:\/\/doi.org\/10.1002\/cpt.204.","journal-title":"Clin Pharmacol Ther"},{"key":"2112_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00551","volume":"11","author":"A Frymoyer","year":"2020","unstructured":"Frymoyer A, Schwenk HT, Zorn Y, et al. Model-informed precision dosing of vancomycin in hospitalized children: implementation and adoption at an academic Children\u2019s Hospital. Front Pharmacol. 2020;11:551. https:\/\/doi.org\/10.3389\/fphar.2020.00551.","journal-title":"Front Pharmacol"},{"key":"2112_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1258","volume":"350","author":"GF Moore","year":"2015","unstructured":"Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: medical research council guidance. BMJ. 2015;350:h1258. https:\/\/doi.org\/10.1136\/bmj.h1258.","journal-title":"BMJ"},{"issue":"2","key":"2112_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/ebnurs-2023-103878","volume":"27","author":"C Bugge","year":"2024","unstructured":"Bugge C. What is a process evaluation when used alongside a randomised controlled trial? Evid Based Nurs. 2024;27(2):45. https:\/\/doi.org\/10.1136\/ebnurs-2023-103878.","journal-title":"Evid Based Nurs"},{"key":"2112_CR16","volume-title":"Qualitative research in nursing and healthcare","author":"I Holloway","year":"2016","unstructured":"Holloway I, Galvin K. Qualitative research in nursing and healthcare. London: Wiley; 2016."},{"issue":"6","key":"2112_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm04","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm04.","journal-title":"Int J Qual Health Care"},{"issue":"3","key":"2112_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1356389016638615","volume":"22","author":"A Manzano","year":"2016","unstructured":"Manzano A. The craft of interviewing in realist evaluation. Evaluation. 2016;22(3):342\u201360. https:\/\/doi.org\/10.1177\/1356389016638615.","journal-title":"Evaluation"},{"issue":"1","key":"2112_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11096-024-01822-x","volume":"47","author":"M Swartling","year":"2025","unstructured":"Swartling M, Hamberg A-K, Furebring M, et al. Model-informed precision dosing of vancomycin in clinical practice: an intervention development study. Int J Clin Pharm. 2025;47(1):178\u201386. https:\/\/doi.org\/10.1007\/s11096-024-01822-x.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"2112_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-0044-1786978","volume":"15","author":"MG Chai","year":"2024","unstructured":"Chai MG, Roberts NA, Dobbins C, et al. Factors influencing integration and usability of Model-Informed Precision Dosing Software in the Intensive Care Unit. Appl Clin Inform. 2024;15(2):388\u201396. https:\/\/doi.org\/10.1055\/s-0044-1786978.","journal-title":"Appl Clin Inform"},{"issue":"3","key":"2112_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/cpt.3510","volume":"117","author":"AC Dibbets","year":"2025","unstructured":"Dibbets AC, Koldeweij C, Osinga EP, et al. Barriers and facilitators for bringing Model-Informed Precision Dosing to the patient\u2019s bedside: a systematic review. Clin Pharmacol Ther. 2025;117(3):633\u201345. https:\/\/doi.org\/10.1002\/cpt.3510.","journal-title":"Clin Pharmacol Ther"},{"key":"2112_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2061","volume":"374","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:n2061. https:\/\/doi.org\/10.1136\/bmj.n2061.","journal-title":"BMJ"},{"key":"2112_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115421","volume":"215","author":"IK Minichmayr","year":"2024","unstructured":"Minichmayr IK, Dreesen E, Centanni M, et al. Model-informed precision dosing: state of the art and future perspectives. Adv Drug Deliv Rev. 2024;215:115421.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"2112_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.addr.2024.115421","volume":"59","author":"JC Euteneuer","year":"2019","unstructured":"Euteneuer JC, Kamatkar S, Fukuda T, et al. Suggestions for model-informed precision dosing to optimize neonatal drug therapy. J Clin Pharmacol. 2019;59(2):168\u201376. https:\/\/doi.org\/10.1016\/j.addr.2024.115421.","journal-title":"J Clin Pharmacol"},{"key":"2112_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00172","volume":"11","author":"D Alihodzic","year":"2020","unstructured":"Alihodzic D, Broeker A, Baehr M, et al. Impact of inaccurate documentation of sampling and infusion time in Model-Informed Precision Dosing. Front Pharmacol. 2020;11:172. https:\/\/doi.org\/10.3389\/fphar.2020.00172.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2112_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/psp4.12745","volume":"11","author":"C Maier","year":"2022","unstructured":"Maier C, de Wiljes J, Hartung N, et al. A continued learning approach for model\u2010informed precision dosing: updating models in clinical practice. CPT Pharmacometrics Syst Pharmacol. 2022;11(2):185\u201398. https:\/\/doi.org\/10.1002\/psp4.12745.","journal-title":"CPT Pharmacometrics Syst Pharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02112-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:31:16Z","timestamp":1784035876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02112-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2112"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02112-4","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No competing interest should be declared. For the research, we received funding from the Belgian Federal Knowledge Centre \u2013 KCE Trials Program grant n\u00b0 18-1128. KCE Trials is a funding program for non-commercial clinical trials financed by the Belgian public authorities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was obtained from the Ethics Committee of UZ Gent\/Ghent University (ONZ-2024\u20130543). Participants received written and verbal information and provided written consent. Data were pseudonymized and stored securely; audio files were deleted prior to manuscript submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}